Bruker Corporation (NASDAQ:BRKR) declared a quarterly dividend on Monday, November 13th, RTT News reports. Shareholders of record on Monday, December 4th will be given a dividend of 0.04 per share by the medical research company on Friday, December 22nd. This represents a $0.16 dividend on an annualized basis and a yield of 0.49%.
Bruker Corporation (BRKR) opened at $32.39 on Tuesday. The company has a debt-to-equity ratio of 0.65, a quick ratio of 1.60 and a current ratio of 2.60. Bruker Corporation has a 1 year low of $21.03 and a 1 year high of $35.16. The firm has a market cap of $5,130.00, a price-to-earnings ratio of 27.20, a price-to-earnings-growth ratio of 2.69 and a beta of 1.05.
Bruker Corporation (NASDAQ:BRKR) last posted its quarterly earnings data on Thursday, November 2nd. The medical research company reported $0.29 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.27 by $0.02. Bruker Corporation had a net margin of 8.85% and a return on equity of 25.83%. The business had revenue of $435.60 million for the quarter, compared to analysts’ expectations of $415.45 million. During the same quarter in the previous year, the business posted $0.32 earnings per share. The business’s revenue was up 10.6% compared to the same quarter last year. equities research analysts expect that Bruker Corporation will post 1.19 EPS for the current fiscal year.
TRADEMARK VIOLATION WARNING: This article was originally published by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are reading this article on another website, it was stolen and republished in violation of United States & international copyright law. The legal version of this article can be read at https://www.dispatchtribunal.com/2017/11/14/bruker-corporation-brkr-to-issue-quarterly-dividend-of-0-04.html.
In other news, VP Mark Munch sold 21,061 shares of Bruker Corporation stock in a transaction on Wednesday, September 13th. The stock was sold at an average price of $29.97, for a total transaction of $631,198.17. Following the transaction, the vice president now directly owns 60,524 shares in the company, valued at approximately $1,813,904.28. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. 35.20% of the stock is owned by insiders.
An institutional investor recently raised its position in Bruker Corporation stock. The Manufacturers Life Insurance Company grew its stake in Bruker Corporation (NASDAQ:BRKR) by 7.1% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 5,003 shares of the medical research company’s stock after purchasing an additional 331 shares during the period. The Manufacturers Life Insurance Company ‘s holdings in Bruker Corporation were worth $144,000 as of its most recent filing with the Securities and Exchange Commission. Institutional investors and hedge funds own 65.47% of the company’s stock.
A number of research analysts have weighed in on the stock. Citigroup Inc. boosted their price objective on shares of Bruker Corporation from $29.00 to $34.00 and gave the company a “neutral” rating in a research report on Friday, November 3rd. Cowen and Company reiterated a “hold” rating and set a $29.00 price objective on shares of Bruker Corporation in a research report on Friday, November 3rd. Zacks Investment Research upgraded shares of Bruker Corporation from a “hold” rating to a “buy” rating and set a $37.00 price target on the stock in a report on Wednesday, November 8th. Bank of America Corporation upgraded shares of Bruker Corporation from an “underperform” rating to a “neutral” rating and set a $34.00 price target on the stock in a report on Friday, November 3rd. Finally, J P Morgan Chase & Co upgraded shares of Bruker Corporation from an “underweight” rating to a “neutral” rating and set a $28.00 price target on the stock in a report on Friday, November 3rd. Two equities research analysts have rated the stock with a sell rating, ten have given a hold rating and four have issued a buy rating to the company. The company currently has an average rating of “Hold” and a consensus target price of $29.64.
Bruker Corporation Company Profile
Bruker Corporation designs and manufactures scientific instruments, and analytical and diagnostic solutions. Its segments include the Bruker BioSpin Group; the Bruker Chemicals, Applied Markets, Life Science, In-Vitro Diagnostics, Detection (CALID) Group; the Bruker Nano Group, and the Bruker Energy & Supercon Technologies (BEST) Segment.
Receive News & Ratings for Bruker Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bruker Corporation and related companies with MarketBeat.com's FREE daily email newsletter.